Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory role of curcumin

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 334-342

  Waseem, Mohammad ^a   Parvez, Suhel ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cisplatin; Curcumin; Hepatotoxicity; Mitochondria; Neurotoxicity; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; CISPLATIN; CURCUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; BRAIN TOXICITY; CELL PROTECTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; LIPID PEROXIDATION; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; CISPLATIN; CURCUMIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDATION; LIVER; MALE; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84872388086     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.055     Document Type: Article

References (72)

1. Al-Majed A.A. Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats. Basic Clin. Pharmacol. Toxicol. 2007, 100:145-150.
2. Amptoulach S., Tsavaris N. Neurotoxicity caused by the treatment with platinum analogues. Chemother. Res. Pract. 2011, 2011:843019.
3. Barzegar A., Moosavi-Movahedi A.A. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 2011, 6:260-272.
4. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem. Pharmacol. 1998, 56:831-839.
5. Brabec V., Kasparkova J. Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist. Updat. 2005, 8:131-146.
6. Burgeiro A., Gajate C., Dakirel H., Villa-Pulgarín J.A., Oliveira P.J., Mollinedo F. Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells. Anticancer Drugs 2011, 22:507-518.
7. Chaudhary S., Parvez S. An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats. Neuroscience 2012, 225:258-268.
8. Chen Y.R., Chen C.L., Zhang L., Green-Church K.B., Zweier J.L. Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation. J. Biol. Chem. 2005, 280:37339-37348.
9. Correi S.C., Carvalho C., Cardoso S., Santos R.X., Santos M.S., Oliveira C.R., Perry G., Zhu X., Smith M.A., Moreira P.I. Mitochondrial preconditioning: a potential neuroprotective strategy. Front. Aging Neurosci. 2010, 2:138.
10. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329:23-38.
11. De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., Mukhopadhyay A.K. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009, 53:1592-1597.
12. Dharap S.S., Wang Y., Chandna P., Khandare J.J., Qiu B., Gunaseelan S., Sinko P.J., Stein S., Farmanfarmaian A., Minko T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. USA 2005, 102:12962-12967.
13. Erkurt M.A., Aydogdu I., Kuku I., Kaya E., Ozhan O. Anticancer drug induced glomerular dysfunction. World J. Med. Sci. 2008, 3:5-9.
14. Eybl V., Kotyzová D., Bludovská M. The effect of curcumin on cadmium-induced oxidative damage and trace elements level in the liver of rats and mice. Toxicol. Lett. 2004, 151:79-85.
15. Floor E., Wetzel M.G. Increased protein oxidation in human substantia nigra parscompacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 1998, 70:268-275.
16. Gaona-Gaona L., Molina-Jijón E., Tapia E., Zazueta C., Hernández-Pando R., Calderón-Oliver M., Zarco-Márquez G., Pinzón E., Pedraza-Chaverri J. Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats. Toxicology 2011, 286:20-27.
17. Garcia J., Han D., Sancheti H., Yap L.P., Kaplowitz N., Cadenas E. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J. Biol. Chem. 2010, 285:39646-39654.
18. Ghezzi P., Romines B., Fratelli M., Eberini I., Gianazza E., Casagrande S., Laragione T., Mengozzi M., Herzenberg L.A. Protein glutathionylation: coupling and uncoupling of glutathione to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol. Immunol. 2002, 38:773-780.
19. González-Salazar A., Molina-Jijón E., Correa F., Zarco-Márquez G., Calderón-Oliver M., Tapia E., Zazueta C., Pedraza-Chaverri J. Curcumin protects from cardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction. Cardiovasc. Toxicol. 2011, 11:357-364.
20. Govil N., Chaudhary S., Waseem M., Parvez S. Postnuclear supernatant: an in vitro model for assessing cadmium-induced neurotoxicity. Biol. Trace Elem. Res. 2012, 146:402-409.
21. Guangwei X., Rongzhu L., Wenrong X., Suhua W., Xiaowu Z., Shizhong W., Ye Z., Aschner M., Kulkarni S.K., Bishnoi M. Curcumin pretreatment protects against acute acrylonitrile-induced oxidative damage in rats. Toxicology 2010, 267:140-146.
22. Guo J., Prokai-Tatrai K., Nguyen V., Rauniyar N., Ughy B., Prokai L. Protein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria. J. Proteomics 2011, 74:2370-2379.
23. Habig W.H., Pabst M., Jaoby W.B. Glutathione S-transferase: the first step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
24. Hall M.D., Okabe M., Shen D.W., Liang X.J., Gottesman M.M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu. Rev. Pharmacol. Toxicol. 2008, 48:495-535.
25. Haque R., Bin-Hafeez B., Parvez S., Pandey S., Sayeed I., Ali M., Raisuddin S. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide induced biochemical toxicity. Hum. Exp. Toxicol. 2003, 22:473-480.
26. Iwata T., Nishiyama N., Nagano K., Izumi N., Mizuguchi S., Tsukioka T., Morita R., Chung K., Hanada S., Inoue K. Role of pulmonary resection in the diagnosis and treatment of limited-stage small cell lung cancer: revision of clinical diagnosis based on findings of resected specimen and its influence on survival. Gen. Thorac. Cardiovasc. Surg. 2012, 60:43-52.
27. Jagatha B., Mythri R.B., Vali S., Bharath M.M. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic. Biol. Med. 2008, 44:907-917.
28. Kamboj S.S., Sandhir R. Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats. Mitochondrion 2011, 11:214-222.
29. Kanbagli O., Balkan J., Aykaç-Toker G., Uysal M. Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats. Biol. Pharm. Bull. 2002, 25:1482-1484.
30. Kartalou M., Essigmann J.M. Mechanisms of resistance to cisplatin. Mutat. Res. 2001, 478:23-43.
31. Kellokumpu-Lehtinen P.L., Hjälm-Eriksson M., Thellenberg-Karlsson C., Aström L., Franzen L., Marttila T., Seke M., Taalikka M., Ginman C. Toxicity in patients receiving adjuvant docetaxel+hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial. Prostate Cancer Prostatic Dis. 2012, 15:303-307.
32. Kim J.H., Jeong S.J., Kwon H.Y., Park S.Y., Lee H.J., Lee H.J., Lieske J.C., Kim S.H. Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells. Biol. Pharm. Bull. 2010, 33:1279-1284.
33. Kluth D., Banning A., Paur I., Blomho V.R., Brigelius-Flohe R. Modulation of pregnane X receptor and electrophile responsive element-mediated gene expression by dietary polyphenolic compound. Free Radic. Biol. Med. 2007, 42:315-325.
34. Lee C.S., Kwak S.W., Kim Y.J., Lee S.A., Park E.S., Myung S.C., Kim W., Lee M.S., Lee J.J. Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways. Eur. J. Pharmacol. 2012, 683:54-62.
35. Li-Ping X., Skrezek C., Wand H., Reibe F. Mitochondrial dysfunction at the early stage of cisplatin-induced acute renal failure in rats. J. Zhejiang Univ. Sci. 2000, 1:91-96.
36. Liu Y., Fiskum G., Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 2002, 80:780-787.
37. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
38. Maggioni D., Nicolini G., Chiorazzi A., Meregalli C., Cavaletti G., Tredici G. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study. J. Neurosci. Res. 2010, 88:3171-3179.
39. Martins N.M., Santos N.A., Curti C., Bianchi M.L., Santos A.C. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Topi. 2008, 28:337-344.
40. Miller R.P., Tadagavadi R.K., Ramesh G., Reeves W.B. Mechanisms of cisplatin nephrotoxicity. Toxins 2010, 2:2490-2518.
41. Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Annu. Indian Acad. Neurol. 2008, 11:13-19.
42. Mruk D.D., Silvestrini B., Mo M.Y., Cheng C.Y. Antioxidant superoxide dismutase - a review: its function, regulation in the testis, and role in male fertility. Contraception 2002, 65:305-311.
43. Mythri R.B., Jagatha B.N., Pradhan J., Andersen M., Bharath M. Mitochondrial complex I inhibition in Parkinsons disease: how can curcumin protect mitochondria?. Antioxid. Redox Signal. 2007, 9:399-408.
44. Nabavi S.F., Moghaddam A.H., Eslami S., Nabavi S.M. Protective effects of curcumin against sodium fluoride-induced toxicity in rat kidneys. Biol. Trace Elem. Res. 2012, 145:369-374.
45. Naqshbandi A., Khan W., Rizwan S., Khan F. Studies on the protective effect of flaxseed oil on cisplatin-induced hepatotoxicity. Hum. Exp. Toxicol. 2012, 31:364-375.
46. Obrenovich M.E., Li Y., Parvathaneni K., Yendluri B.B., Palacios H.H., Leszek J., Aliev G. Antioxidants in health, disease and aging. CNS Neurol. Disord. Drug Targets 2011, 10:192-207.
47. Ognjanovic B.I., Djordjevic N.Z., Matic M.M., Obradovic J.M., Mladenovic J.M., Stajn A.S., Saicic Z.S. Lipid peroxidative damage on Cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int. J. Mol. Sci. 2012, 13:1790-1803.
48. özyurt B., Güleç M., özyurt H., Ekici F., Atis ö., Akbas A. The effect of antioxidant caffeic acid phenethyl ester (cape) on some enzyme activities in cisplatin-induced neurotoxicity in rats. Eur. J. Gen. Med. 2006, 3:167-172.
49. Parvez S., Tabassum H., Banerjee B.D., Raisuddin S. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic Clin. Pharmacol. Toxicol. 2008, 102:382-387.
50. Parvez S., Winkler-Stuck K., Hertel S., Schönfeld P., Siemen D. The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca2+-triggered permeability transition of mitochondria. Biochim. Biophys. Acta 2010, 1797:1245-1250.
51. Qian W., Nishikawa M., Haque A.M., Hirose M., Mashimo M., Sato E., Inoue M. Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death. Am. J. Physiol. Cell Physiol. 2005, 289:1466-1475.
52. Raza H., John A., Benedict S. Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells. Eur. J. Pharmacol. 2011, 668:15-24.
53. Rezvanfar M.A., Farshid A.A., Sadrkhanlou R.A., Ahmadi A., Rezvanfar M.A., Salehnia A., Abdollahi M. Benefit of Satureja khuzestanica in subchronically rat model of cyclophosphamide-induced hemorrhagic cystitis. Exp. Toxicol. Pathol. 2010, 62:323-330.
54. Rinne M.L., Lee E.Q., Wen P.Y. Central nervous system complications of cancer therapy. J. Support. Oncol. 2012, 10:133-141.
55. Rodriguez-Menendez V., Gilardini A., Bossi M., Canta A., Oggioni N., Carozzi V., Tremolizzo L., Cavaletti G. Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study. Anticancer Res. 2008, 28:335-342.
56. Sarkar F.H., Li Y., Wang Z., Padhye S. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr. Pharm. Des. 2010, 16:1801-1812.
57. Sedletska Y., Giraud-Panis M.J., Malinge J.M. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr. Med. Chem. 2005, 5:251-265.
58. Shoeb M. Anticancer agents from medicinal plants. Bangladesh J. Pharmacol. 2006, 1:35-41.
59. Singh R., Sharma P. Hepatoprotective effect of curcumin on lindane-induced oxidative stress in male Wistar rats. Toxicol. Int. 2011, 18:124-129.
60. Somparn P., Phisalaphong C., Nakornchai S., Unchern S., Morales N.P. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharm. Bull. 2007, 30:74-88.
61. Sood P.K., Nahar U., Nehru B. Curcumin attenuates Aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain. Neurotox. Res. 2011, 20:351-361.
62. Srinivasan S., Pari L. Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem. Biol. Interact. 2012, 195:43-51.
63. Swamy A.V., Gulliaya S., Thippeswamy A., Koti B.C., Manjula D.V. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J. Pharmacol. 2012, 44:73-77.
64. Tabassum H., Parvez S., Pasha S.T., Banerjee B.D., Raisuddin S. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem. Toxicol. 2010, 48:1973-1979.
65. Tabassum H., Parvez S., Rehman H., Banerjee B.D., Raisuddin S. Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-induced protein oxidation and lipid peroxidation. J. Biochem. Mol. Toxicol. 2007, 21:110-117.
66. Tang M.H., Chiu P.Y., Ko K.M. Hepatoprotective action of schisandrin B against carbon tetrachloride toxicity was mediated by both enhancement of mitochondrial glutathione status and induction of heat shock proteins in mice. Biofactors 2003, 19:33-42.
67. Tucci P., Cione E., Perri M., Genchi G. All-trans-retinoic acid induces apoptosis in Leydig cells via activation of the mitochondrial death pathway and antioxidant enzyme regulation. J. Bioenerg. Biomembr. 2008, 40:315-323.
68. Wang M.E., Chen Y.C., Chen I.S., Hsieh S.C., Chen S.S., Chiu C.H. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J. Nutr. Biochem. 2012, 35:1352-1366.
69. Wei Q.Y., Chen W.F., Zhou B., Yang L., Liu Z.L. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta 2006, 1760:70-77.
70. Yadav R.S., Chandravanshi L.P., Shukla R.K., Sankhwar M.L., Ansari R.W., Shukla P.K., Pant A.B., Khanna V.K. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology 2011, 32:760-768.
71. Zeng T., Zhang C.L., Zhu Z.P., Yu L.H., Zhao X.L., Xie K.Q. Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology 2008, 252:86-91.
72. Zhang X., Yeung E.D., Wang J., Panzhinskiy E.E., Tong C., Li W., Li J. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin. Exp. Pharmacol. Physiol. 2010, 37:841-847.